After the hump: Pfizer-AstraZeneca combo on downhill slope
This article was originally published in Scrip
Executive Summary
Pfizer's CEO Ian Read underlined the complementary nature of Pfizer and AstraZeneca in laying out the rationale for a merger of the two. The outlook for the various franchises of each company separately tells a different story, however.